Showing results (741-750 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|January 1, 1986
The effect of zimelidine, a serotonin-reuptake blocker, on cataplexy and daytime sleepiness of narcoleptic patientsR Godbout, J MontplaisirClinical Neuropharmacology|August 18, 2017
School Refusal Successfully Treated With DivalproexLu Ye, Jeongwon Shin, Steven LippmannClinical Neuropharmacology|August 18, 2017
Reversible Splenial Lesion Syndrome After Intravenous Immunoglobulin Treatment for Guillain-Barre SyndromeElif Uygur Kucukseymen, Burcu Yuksel, Fatma Genc, et al.Clinical Neuropharmacology|January 22, 2002
Dyskinesia: L-dopa-induced and tardive dyskinesiaO Rascol, N FabreClinical Neuropharmacology|January 22, 2002
Intravenous magnesium sulfate does not increase ventricular CSF ionized magnesium concentration of patients with intracranial hypertensionR P Brewer, A Parra, C O Borel, et al.Clinical Neuropharmacology|January 22, 2002
Switching from bromocriptine to ropinirole in patients with advanced Parkinson's disease: open label pilot responses to three different dose-ratiosS Giménez-Roldán, E M Esteban, D MateoClinical Neuropharmacology|January 22, 2002
Controlled pilot study of piracetam for pediatric opsoclonus-myoclonusM R Pranzatelli, E D Tate, I Galvan, et al.Clinical Neuropharmacology|April 6, 2001
Incoherence of neuroimaging studies of attention deficit/hyperactivity disorderA A Baumeister, M F HawkinsClinical Neuropharmacology|April 6, 2001
Catechol-O-methyltransferase decreases levodopa toxicity in vitroD Offen, H Panet, R Galili-Mosberg, et al.Clinical Neuropharmacology|January 12, 2001
The effect of sertraline on routine blood chemistry valuesM C Catalano, G Catalano, S N Kanfer, et al.Pageof 236